This study aimed to assess the uptake and use by general practitioners of a free epilepsy audit protocol, and describe the care provided by practices which returned completed audits. A protocol for epilepsy audit in general practice was designed and described in the medical press. Practices were invited to reply. Responders were provided with the protocol. A total of 215 practices responded to the articles in the press. Questionnaires asking how they had used the audit protocol were sent to them 18 months later. One hundred and seventy (79%) of the 215 responding practices returned the questionnaires. Forty-seven.(28%) had collected some or all of the data. Twenty-two (13%) submitted data of which 12 (7%) matched the original protocol. Aggregated list sizes for these 12 practices was 75 689 and 502 (0.66%) patients were being treated. Of these, 60% were seizure free and 11% were having more than one seizure per month. Seventy-one were receiving monotherapy and only two patients were taking more than three drugs. Eighty-eight per cent of patients still having seizures had been seen by their GP for their epilepsy in the last 12 months. In 18% of cases, information on epilepsy lifestyle issues had been given and noted. Offering a free epilepsy audit package can stimulate interest amongst practices in the topic and resulted in 13% collecting and submitting their data for analysis. Practices reported a higher prevalence for epilepsy (0.66%) than in previous studies. The majority of patients with active epilepsy (88%) had been seen by a general practitioner in the last 12 months. Most (710/ ) o were receiving monotherapy, but recording of seizure frequency and provision of information about epilepsy was low.
INTRODUCTION
There are over 25OOOQ people being treated for epilepsy in the UK'. There is controversy over who should care for them. Some advocate an expansion of neurology services*, whilst others argue that the large numbers of patients with epilepsy and changes in the structure of the National Health Service mean that most of their care will be in the primary sector3*4. The 'Epilepsy Needs Document" has outlined standards for epilepsy management and recommends that general practitioners have a major role in the recognition of the condition and in long-term care for patients whose condition has stabilized.
Audit can be a powerful tool for education and change and is a required activity for general practitioners!. Current epilepsy care, as described by enthusiastic general practitioners, leaves room for improvement.
Studies of epilepsy management in general practice have suggested that patients are not seen frequently enough, are not provided with enough information and advice about their condition, and that record keeping is poor . y 7-11 Ta lor however, has shown in sucessive practice audits that seizure frequency and quality of life for patients with epilepsy can be improved12.
As representatives of an organization with an interest in improving care for patients with The aims of this study were to: (1) assess the uptake and use of a freely available audit package; and (2) describe current levels of care in corresponding practices.
completing the audit in the next 18 months; seven were definitely interested in completing the audit at sometime, but had no date set; 45 were possibly interested in completing the audit and requested a further copy; 61 were no longer interested in completing the audit.
Practices submitting data in the exact format (n= 12) METHODS A package was designed from previously published audits7,9-'3, which was easy to use, quick to complete, and would produce useful data. The format was finalized after piloting in two practices and is available from the authors.
Practices were encouraged to set their own standards for care by asking them to consider various aspects of epilepsy management. Collated data was offered so that practices could compare their care with others.
Articles about the audit package were placed in the general practice press (Doctor, Pulse, MIMS Magazine, May 1992). Practices were invited to send for a copy of the free protocol which they received by post. No financial inducements were offered.
In November 1993, a second letter was sent to practices who requested the audit package with a questionnaire (copies available from the authors) asking how far they had proceeded with the audit, and whether they would share their data anonymously.
Data received from practices was analysed on SPSS/PC+, version 4.0.
RESULTS

Responding practices (n = 215)
A total of 215 practices responded to the three medical press articles and requested an audit protocol. One hundred and seventy (79%) of these completed and returned the follow-up questionnaire. Forty-seven (28%) reported some audit activity, of which 22 (13%) have submitted data. The 148 (87%) practices who completed the questionnaire but did not submit data fell into the following categories: six had completed another epilepsy audit; seven had completed the audit, but did not want to share their data; 12 had started the audit, but were only able to collect some of the data; 10 said they would be Practices varied in size from 1861 to 11000 patients. All types of practices were represented throughout England and Wales. Practices were not biased towards areas noted for their specialist epilepsy services. No data is available from non-responding practices.
The total patient population of the 12 practices was 75 689 with 502 (0.66%) receiving treatment for epilepsy. The percentage of patients being treated per practice varied from 0.43 to 0.86%.
Patients being treated (n = 502) Of the patients being treated, 251 (50%) were male and 251 (50%) female. Only 70 (15%) were aged 20 or less.
Seizure frequecy and recording
Three hundred and seven (61%) of patients had a record of seizure frequency in their notes. Of these, 185 (60%) were seizure free, 79 (26%) were having six or less seizures per annum, but 33 (11%) were having more than one seizure per month and 22 (7%) four or more seizures per month.
Number and type of drugs (n = 502) Of the 502 patients, 354 (71%) were receiving monotherapy, 122 (24%) were taking two drugs, 24 (5%) three drugs, and only two patients greater than three. Of the patients who were seizure free (n = 185), 145 (78%) achieved this on monotherapy, 36 (20%) on two drugs, and four (2%) on three drugs.
The most commonly used drugs were phenytoin, carbamazepine and sodium valproate. Only 21 (4%) of patients were taking one of the three new antiepileptics licensed at the time. Prescriptions (n = 502) In 397 (79%) of cases, it was stated that the prescription presently issued matched the notes. Some computerized practices felt this question had little relevance, as their prescribing was generated from their computer system.
Of the 122 (40%) patients who had seizures in the previous 12 months, 95 (78%) of the prescriptions matched the notes.
Frequency of consultation
Three hundred and twenty-seven (68%) of patients had a record of being seen for their epilepsy by their GP in the last 12 months. Of those who were still having seizures (n = 122) 104 (88%) had been seen by their GP for their epilepsy in the last 12 months.
A total of 396 (79%) had a record in their general practice notes of being seen by a hospital consultant for their epilepsy. Of these, 190 (48%) had been seen in the last 12 months. Of the patients still having seizures (n = 122) 81 (75%) had been seen in the last 12 months and where patients were having 12 or more seizures per year (n = 35) the hospital follow up in the last 12 months was higher at 80%.
Information provision (n = 502) Ninety-one (18%) of the patient notes scrutinized contained evidence of information provision on epilepsy and its potential lifestyle issues.
Practice comments on audit
Practices reported a number of interesting activities after completing the audit. Many have placed special epilepsy record cards in the notes. Two practices have held 'open days' for patients with epilepsy, where. people were invited to attend and discuss any worries they had. One practice has started a specialist epilepsy clinic and 80% of patients approached have already attended the clinic.
DISCUSSION
Publicity about a free audit package through the popular medical press encouraged over 200 practices to respond. This represents 2% of all practices in the UK and the exercise has been useful in raising epilepsy as a topic in many more practices. The audit package seems to have stimulated responders to undertake audit activity in an area of medical care which has been amply demonstrated to be capable of improvement. Other patient-oriented organizations may wish to consider this route of influencing practices to change their behaviour since it has the merits of being efficient in the use of time and money.
Since the audit package was designed to provoke discussion in the practices and to be flexible in the information sought, many practices chose to collect data in a way which was not compatible with other practices. Thus collated data presented in this study has come from 12 practices providing care for 502 patients with epilepsy. Although larger studies have been reported'*15, there are some differences in the data from this study compared with others previously published in (1) prevalence, (2) seizure frequency, (3) follow-up and (4) use of drugs13-15.
Comparing prevalence of epilepsy in various studies is difficult16 because of the differences in populations studied and in the selection criteria chosen to define epilepsy. Prevalence in this study was 0.66%, rather higher than the 0.40%14 and 0.37%15 in previously published studies using similar selection criteria.
The increase may be due to a true increase in the prevalence of treated epilepsy in general practice. One explanation may be the trend towards community care for patients with leaming disabilities, many of whom will now be cared for by a general practitioner instead of a hospital. Alternatively, the increase may be accounted for by better definition of cases following the improvements in practice information systems brought about by computerization.
Three hundred and seven (61%) patients had seizure frequency recorded. Of these, 122 (40%) were still having seizures, but only 22 (7%) were having four or more seizures per month. This means 100 (33%) were having relatively infrequent seizures. This group of patients rarely enter surgical or drug research programmes, but are a group who may respond well to active intervention and re-referral. As only 4% of patients were taking one of the new antiepileptics there appeared to be little evidence that active intervention was occurring.
Drug usage has changed compared to previous studies. The proportion of patients on monotherapy is higher at 71%, compared with about 50% in other studies'4V'5. The use of carbamazepine and sodium valproate has increased compared to the use of phenytoin and phenobarbitone. This reflects recommendations to prescribe fewer drugs with less toxicity'.
Sixty-eight per cent of patients had a record of having been seen specifically for their epilepsy by their GP in the last 12 months. It is difficult to compare this with previous studies, as different measures have been used for follow-up, but Lloyd-Jones' found that 60% had not seen a doctor at all in the past year. Whilst opportunities for general practitioners to review their patients with epilepsy may have increased, there are still over 30% with no record of their epilepsy care having been considered in the last year.
Patients' quality of life is impaired if they continue to experience seizures, and deteriorates with more frequent seizures". Patients with epilepsy express a desire for more information and advice about their condition". Seizure frequency was not recorded in approximately 40% and information about epilepsy was infrequently recorded as having been given (18%).
CONCLUSIONS
Providing information about a freely available audit package stimulated a good response from practices and resulted in a reasonable proportion undertaking audit activity.
Most people with epilepsy are being seen regularly by their general practitioner, but there are still a worrying number of people still having seizures that have not been seen by a specialist for over 12 months. With the advent of new drugs offering improved seizure control and better success of surgical techniques, this needs a reappraisal. General practitioners should consider re-referring patients who have unacceptable side-effects or continue to have seizures, however frequent.
Certain aspects of care, notably a trend towards monotherapy and less toxic drugs, had improved compared with previous published audits. However, recording of seizure frequency and information provision was under-utilized.
Until general practice improves these facets of epilepsy care it is unlikely that quality of life for patients with epilepsy will be increased through reduced seizures and an increase in knowledge about their condition.
